Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,368
Closed -$2.58M 211
2021
Q1
$2.58M Buy
10,368
+385
+4% +$91.9K 0.03% 187
2020
Q4
$2.29M Hold
9,983
0.03% 186
2020
Q3
$2.54M Sell
9,983
-41
-0.4% -$10.2K 0.03% 175
2020
Q2
$2.36M Sell
10,024
-1,039
-9% -$237K 0.03% 170
2020
Q1
$2.24M Buy
11,063
+977
+10% +$213K 0.04% 161
2019
Q4
$2.43M Sell
10,086
-496
-5% -$109K 0.03% 161
2019
Q3
$2.05M Buy
10,582
+671
+7% +$129K 0.03% 165
2019
Q2
$1.83M Sell
9,911
-3,900
-28% -$698K 0.02% 179
2019
Q1
$2.62M Sell
13,811
-274
-2% -$52.3K 0.03% 170
2018
Q4
$2.74M Buy
14,085
+190
+1% +$37.1K 0.04% 162
2018
Q3
$2.88M Sell
13,895
-212
-2% -$41.8K 0.04% 161
2018
Q2
$2.6M Buy
14,107
+353
+3% +$62.4K 0.03% 161
2018
Q1
$2.35M Sell
13,754
-1,404
-9% -$258K 0.03% 160
2017
Q4
$2.64M Buy
15,158
+35
+0.2% +$6.19K 0.04% 156
2017
Q3
$2.82M Hold
15,123
0.04% 155
2017
Q2
$2.6M Buy
+15,123
New +$2.46M 0.03% 155

Other funds holding AMGN

Capital Bank & Trust's AMGN Position: Q2 2021 in Review

Capital Bank & Trust sold out of Amgen (AMGN) in Q2 2021, closing a stake of 10,368 shares — an estimated $2.58M sold.

Capital Bank & Trust first reported a position in AMGN in Q2 2017 and held it in 16 quarters. The position peaked at $2.88M in Q3 2018. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Capital Bank & Trust reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 10,368 Amgen shares in Q2 2021, an estimated $2.58M.
  • Capital Bank & Trust first reported a position in Amgen in Q2 2017 and held it in 16 quarters.
  • Capital Bank & Trust's Amgen position peaked at $2.88M in Q3 2018.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.